Dmitrii Grachev

1 article listing Dmitrii Grachev in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial Nature Communications